Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis

BACKGROUND: Sustaining clinical remission is an important treatment goal in moderate-to-severe UC. This post hoc exploratory analysis assessed the long-term efficacy of vedolizumab in the subset of patients with UC in the GEMINI 1 study who were in clinical remission by week 14 after 3 induction dos...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Inflamm Bowel Dis
Κύριοι συγγραφείς: Feagan, Brian G, Schreiber, Stefan, Wolf, Douglas C, Axler, Jeffrey L, Kaviya, Arpeat, James, Alexandra, Curtis, Rebecca I, Geransar, Parnia, Stallmach, Andreas, Ehehalt, Robert, Bokemeyer, Bernd, Khalid, Javaria Mona, O’Byrne, Sharon
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Oxford University Press 2019
Θέματα:
Original Clinical Articles
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6499937/
https://ncbi.nlm.nih.gov/pubmed/30365009
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ibd/izy323
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια